Fate Therapeutics Inc (NASDAQ:FATE) has 139 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Redmile Group, LLC | 31 Dec, 2025 | 12,872,946 | 0 | 0.00% | $12,648,957.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 10,176,487 | -504,240 | -4.72% | $9,999,415.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 8,971,347 | 172,856 | 1.96% | $8,818,834.00 |
| Johnson & Johnson | 31 Dec, 2025 | 6,758,128 | 0 | 0.00% | $6,640,536.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 2,931,893 | 221,659 | 8.18% | $2,878.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 2,870,080 | 1,383,673 | 93.09% | $2,820,140.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,468,348 | -61,864 | -2.45% | $2,425,764.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 2,360,881 | 1,098,366 | 87.00% | $2,319,802.00 |
| State Street Corp | 31 Dec, 2025 | 2,265,217 | -151,918 | -6.29% | $2,225,802.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 1,734,064 | 833,307 | 92.51% | $1,703,891.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 1,725,000 | -790,000 | -31.41% | $1,694,985.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 1,651,700 | 644,300 | 63.96% | $1,622,960.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 1,577,478 | -517,497 | -24.70% | $1,550,034.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 1,527,986 | 1,527,986 | 0.00% | $1,501,399.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,167,773 | -700,000 | -37.48% | $1,147,454.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,162,005 | 30,591 | 2.70% | $1,141,787.00 |
| Morgan Stanley | 31 Dec, 2025 | 916,946 | -12,998 | -1.40% | $900,990.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 842,807 | 239,046 | 39.59% | $828,142.00 |
| Monaco Asset Management SAM | 31 Dec, 2025 | 830,000 | 60,000 | 7.79% | $815,558.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 784,628 | -1,293 | -0.16% | $770,975.00 |